Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.

Anticancer research - 1 Jan 2000

Curigliano G, Ferretti G, Flamini G, Goldhirsch A, de Braud F, Calabro M G, Mandaly M, Nole F, De Pas T, D'Addessi A, Cittadini A

Abstract excerpt

OBJECTIVE: The diagnosis and follow-up of patients with T1 bladder cancer relies invasive procedures. We developed a non-invasive method for detection of T1 bladder cancer based on a feasible non-radioactive molecular approach. MATERIALS AND METHODS: Urine DNA samples were collected from 24 patients with T1 transitional cell carcinoma (TCC) of the bladder and were processed by denaturing gradient gel...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Transitional Cell
Share to Electrophoresis, Polyacrylamide Gel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Feasibility Studies

Share to Genes, p53

Share to Neoplasm Recurrence, Local

Share to Nucleic Acid Denaturation

Share to Urinalysis

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 11712804

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.PMID 11712804Read ↗

Mutation of the tumor suppressor gene p53 in human prostate and bladder cancers--investigation by temperature gradient gel electrophoresis (TGGE).Semantic proximity Read ↗

Genetic analysis of Tp53 from urine sediment as a tool for diagnosing recurrence and residual of bladder carcinoma.Semantic proximity Read ↗

Diagnosis of bladder cancer by analysis of the allelic loss of the p53 gene in urine samples using blunt-end single-strand conformation polymorphism.Semantic proximity Read ↗

TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.Semantic proximity Read ↗

Telomerase reverse transcriptase mutation and the p53 pathway in T1 urinary bladder cancer.Semantic proximity Read ↗

MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1.Semantic proximity Read ↗

Clinical implications of p53 mutation analysis in bladder cancer tissue and urine sediment by functional assay in yeast.Semantic proximity Read ↗

Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers.Semantic proximity Read ↗

TP53 - molecular soldier's mutations in bladder cancer in the Kashmiri population.Semantic proximity Read ↗

Progression in transitional cell carcinoma of the urinary bladder--analysis of Tp53 gene mutations by temperature gradients and sequence in tumor tissues and in cellular urine sediments.Semantic proximity Read ↗

p53 mutations detection in urinary bladder cancer in the Greek population: application of the NIRCA assay.Semantic proximity Read ↗

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.